Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 20, 1997

View Archived Issues

NCI study indicates potential teratogenicity of AZT

Abbott isolates fusacandin antifungal agents

Daikin synthesizes new ganglioside compounds

New ACAT inhibitors claimed by DuPont Merck

Heterocyclic MDR inhibitors reported by Pfizer

Mayo Foundation reports new natriuretic peptide

Anti-IL-2 monoclonal antibody described by Ajinomoto

More antiobesity proteins in the pipeline at Lilly

cAMP PDE inhibitors disclosed by Nippon Kayaku

Aquila adjuvant shows promise as component of malaria vaccine

New wound-healing agents reported

New amylin antagonists from Amylin

Faulding expands into Europe

Phase II trials begin on ICOS MS treatment

EntreMed licenses dual cytotoxic/antiangiogenic compound

Troglitazone price-listed in Japan

JT to launch new imaging agent soon in Japan

Takeda claims new approach to diabetes Rx

Triangle reports preliminary clinical results with anti-HIV compound

Mochida claims new formulation for ulinastatin

IVAX and Knoll modify European alliance

Adeza obtains clearance for supplementary PMA

Forbes files for U.S. patent related to membrane deficiencies

Zeneca's right to sell prostate cancer drug upheld

Medtronic's arrhythmia management device enters clinic

Olopatadine studied for allergic conjunctivitis

BMS antidepressant chosen for important multiinstitutional trial

Ibopamine efficacy in patients with chronic progressive renal failure

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...